A new report shows that women aged 12-29 who received AstraZeneca/Oxford University’s Vaxzevria adenovirus vectored COVID-19 vaccine are three and a half times more likely to develop heart disease, suffer sudden death, or both, in the 12 days post vaccination.1 The statistical model linked 11...